Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds RSS Feed PharmiWeb Candidate Blog RSS Feed PharmiWeb Client Blog


Press Release

CHI Franciscan Health Selects Glytec’s eGMS® for Precision Diabetes Management

Posted on: 22 Sep 16

CHI Franciscan Health of Tacoma, Washington has recently turned to Glytec for its comprehensive eGlycemic Management System®, or eGMS®, which includes FDA-cleared technology for both intravenous and subcutaneous real-time insulin dosing.

This Smart News Release features multimedia. View the full release here:

“Proper glucose control among our inpatient population is truly essential to providing high-quality, cost-effective care,” explains Tim Lynch, PharmD, MS, division director of Pharmacy and residency director at CHI Franciscan Health. “Glytec’s solution suite will allow us to meet the broader requirements of our health system.” (Photo: Business Wire)

“Proper glucose control among our inpatient population is truly essential to providing high-quality, cost-effective care,” explains Tim Lynch, PharmD, MS, division director of Pharmacy and residency director at CHI Franciscan. “Glytec’s solution suite will allow us to meet the broader requirements of our health system.”

CHI Franciscan will implement Glytec’s eGMS® across all eight of its full-service hospitals. The eGMS® will support glycemic management in critical care and intensive care units as well as medical/surgical floors and emergency departments. The health system has subscribed to multiple eGMS® modules, including Glucommander™, GlucoMetrics®, GlucoSurveillance®, GlucoView® and SmartClick®. The software-as-a-service (SaaS) solution suite offers access to proprietary insulin dosing algorithms, robust analytics and reporting, automated surveillance and alerting, and more. It also offers integration with electronic medical record (EMR) systems and connected devices.

“The fact Glytec’s eGMS® will be integrated with our Epic electronic medical record is a real advantage,” adds Lynch. “Any longer, this is a requirement for new healthcare technology.”

It is expected that CHI Franciscan will have more than 5,000 Glucommander™ users and prescribers. Included among them will be endocrinologists, hospitalists and other MDs as well as pharmacists, nurses and diabetes educators. The Glytec clinical services organization will work closely with the CHI Franciscan glycemic management committee to tailor the eGMS® to specific workflows, protocols and preferences.

“Our primary goal with CHI Franciscan is to make sure we tailor our solution suite to achieve the results they are seeking, and help them improve outcomes,” says Melanie Mabrey, DNP, ACNP-BC, BC-ADM, CDTC, FAANP, Vice President of Clinical Practice at Glytec. “They have a lot of experience in glycemic management and a lot of great ideas. They will be an exciting partner for Glytec.”

About Glytec

As a leading innovator in the care of patients with diabetes, Glytec is pioneering the way hospitals and health systems use technology to ensure optimal glucose control and prevent the associated frequency, risks and costs of hyperglycemia and hypoglycemia. The company, founded in 2006, has developed a comprehensive eGlycemic Management System®, or eGMS®, which centers on the only FDA-cleared solution for insulin dosing able to support personalized, real-time intravenous and subcutaneous therapy for adult and pediatric populations across the entire care continuum. The solution seamlessly integrates with EMR systems for streamlined use in all inpatient and outpatient settings. It also integrates with connected devices for at-home care managed through telehealth, population health and other value-based programs. The eGMS® employs a cloud-hosted software-as-a-service (SaaS) delivery model, allowing for rapid implementation and anytime/anywhere access. The efficacy of the eGMS®, including its ability to substantively improve clinical and financial outcomes, has been validated by more than 55 published studies. Results have included dramatic reductions in lengths of stay, readmissions and ALc levels. Glytec currently holds five U.S. patents and has more than 30 U.S. and international patents pending. The company has offices in Waltham, Massachusetts and Greenville, South Carolina. For more information, visit

About CHI Franciscan Health

CHI Franciscan Health is a nonprofit health system based in Tacoma, Washington with a team of more than 12,000 doctors, nurses and staff that provide expert, compassionate medical care at eight acute care hospitals and approximately 200 primary and specialty care clinics in Pierce, King and Kitsap counties. This includes St. Anthony Hospital, Gig Harbor; St. Clare Hospital, Lakewood; St. Elizabeth Hospital, Enumclaw; St. Francis Hospital, Federal Way; St. Joseph Medical Center, Tacoma; Harrison Medical Center, Bremerton and Silverdale; Highline Medical Center, Burien; and Regional Hospital, Burien. Started in 1891 by the Sisters of St. Francis of Philadelphia, today CHI Franciscan Health is one of the largest health systems in Washington state. The system spans more than 1,100 acute care beds, a credentialed medical staff of more than 2,201 including more than 800 employed physicians providing specialties in cardiovascular care, cancer care, orthopedics and sports medicine, neurosciences and women’s care. CHI Franciscan’s mission focuses on creating healthier communities, including caring for the poor and underserved. In 2016, the organization provided $156 million in community benefit, including $9 million in charity care. More information:

View source version on

Business Wire

Last updated on: 22/09/2016

Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.